FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2591750377> ?p ?o ?g. }

• W2591750377 endingPage "2032" @default.
• W2591750377 startingPage "2025" @default.
• W2591750377 abstract "Resistance to anticancer medications often leads to poor outcomes. The present study explored an effective approach for enhancing chemotherapy targeted against human cancer cells. Real-time quantitative real-time polymerase chain reaction (qRT-PCR) analysis revealed overexpression of members of aldo-keto reductase (AKR) 1C family, AKR1C1, AKR1C2, AKR1C3, and AKR1C4, in cisplatin, cis-diamminedichloroplatinum (II) (CDDP)-resistant human cancer cell lines, HeLa (cervical cancer cells) and Sa3 (oral squamous cell carcinoma cells). The genes were downregulated using small-interfering RNA (siRNA) transfection, and the sensitivity to CDDP or 5-fluorouracil (5-FU) was investigated. When the genes were knocked down, sensitivity to CDDP and 5-FU was restored. Furthermore, we found that administration of mefenamic acid, a widely used non-steroidal anti-inflammatory drug (NSAID) and a known inhibitor of AKR1Cs, enhanced sensitivity to CDDP and 5-FU. The present study suggests that AKR1C family is closely associated with drug resistance to CDDP and 5-FU, and mefenamic acid enhances their sensitivity through its inhibitory activity in drug-resistant human cancer cells. Thus, the use of mefenamic acid to control biological function of AKR1C may lead to effective clinical outcomes by overcoming anticancer drug resistance." @default.
• W2591750377 created "2017-03-16" @default.
• W2591750377 creator A5006900657 @default.
• W2591750377 creator A5016963706 @default.
• W2591750377 creator A5017712077 @default.
• W2591750377 creator A5019406796 @default.
• W2591750377 creator A5023110293 @default.
• W2591750377 creator A5027580659 @default.
• W2591750377 creator A5055457176 @default.
• W2591750377 creator A5057611207 @default.
• W2591750377 creator A5081723799 @default.
• W2591750377 creator A5082329874 @default.
• W2591750377 date "2017-03-01" @default.
• W2591750377 modified "2023-09-30" @default.
• W2591750377 title "Mefenamic acid enhances anticancer drug sensitivity via inhibition of aldo-keto reductase 1C enzyme activity" @default.
• W2591750377 cites W1604507293 @default.
• W2591750377 cites W1965788245 @default.
• W2591750377 cites W1979107490 @default.
• W2591750377 cites W1980635047 @default.
• W2591750377 cites W1984328540 @default.
• W2591750377 cites W1998971866 @default.
• W2591750377 cites W1999064503 @default.
• W2591750377 cites W2001376129 @default.
• W2591750377 cites W2003178923 @default.
• W2591750377 cites W2011645692 @default.
• W2591750377 cites W2011974240 @default.
• W2591750377 cites W2012461070 @default.
• W2591750377 cites W2015561372 @default.
• W2591750377 cites W2023007598 @default.
• W2591750377 cites W2026546941 @default.
• W2591750377 cites W2036021808 @default.
• W2591750377 cites W2046334666 @default.
• W2591750377 cites W2078144803 @default.
• W2591750377 cites W2078882789 @default.
• W2591750377 cites W2078988395 @default.
• W2591750377 cites W2082445955 @default.
• W2591750377 cites W2084472043 @default.
• W2591750377 cites W2085028669 @default.
• W2591750377 cites W2108630902 @default.
• W2591750377 cites W2130177169 @default.
• W2591750377 cites W2138873293 @default.
• W2591750377 cites W2165535625 @default.
• W2591750377 cites W4205877643 @default.
• W2591750377 doi "https://doi.org/10.3892/or.2017.5480" @default.
• W2591750377 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28259989" @default.
• W2591750377 hasPublicationYear "2017" @default.
• W2591750377 type Work @default.
• W2591750377 sameAs 2591750377 @default.
• W2591750377 citedByCount "37" @default.
• W2591750377 countsByYear W25917503772018 @default.
• W2591750377 countsByYear W25917503772019 @default.
• W2591750377 countsByYear W25917503772020 @default.
• W2591750377 countsByYear W25917503772021 @default.
• W2591750377 countsByYear W25917503772022 @default.
• W2591750377 countsByYear W25917503772023 @default.
• W2591750377 crossrefType "journal-article" @default.
• W2591750377 hasAuthorship W2591750377A5006900657 @default.
• W2591750377 hasAuthorship W2591750377A5016963706 @default.
• W2591750377 hasAuthorship W2591750377A5017712077 @default.
• W2591750377 hasAuthorship W2591750377A5019406796 @default.
• W2591750377 hasAuthorship W2591750377A5023110293 @default.
• W2591750377 hasAuthorship W2591750377A5027580659 @default.
• W2591750377 hasAuthorship W2591750377A5055457176 @default.
• W2591750377 hasAuthorship W2591750377A5057611207 @default.
• W2591750377 hasAuthorship W2591750377A5081723799 @default.
• W2591750377 hasAuthorship W2591750377A5082329874 @default.
• W2591750377 hasBestOaLocation W25917503771 @default.
• W2591750377 hasConcept C114851261 @default.
• W2591750377 hasConcept C121608353 @default.
• W2591750377 hasConcept C1491633281 @default.
• W2591750377 hasConcept C2776694085 @default.
• W2591750377 hasConcept C2777366897 @default.
• W2591750377 hasConcept C2778239845 @default.
• W2591750377 hasConcept C2778475344 @default.
• W2591750377 hasConcept C2780035454 @default.
• W2591750377 hasConcept C2781018059 @default.
• W2591750377 hasConcept C29537977 @default.
• W2591750377 hasConcept C502942594 @default.
• W2591750377 hasConcept C54355233 @default.
• W2591750377 hasConcept C55493867 @default.
• W2591750377 hasConcept C86803240 @default.
• W2591750377 hasConcept C89423630 @default.
• W2591750377 hasConcept C96232424 @default.
• W2591750377 hasConcept C98274493 @default.
• W2591750377 hasConceptScore W2591750377C114851261 @default.
• W2591750377 hasConceptScore W2591750377C121608353 @default.
• W2591750377 hasConceptScore W2591750377C1491633281 @default.
• W2591750377 hasConceptScore W2591750377C2776694085 @default.
• W2591750377 hasConceptScore W2591750377C2777366897 @default.
• W2591750377 hasConceptScore W2591750377C2778239845 @default.
• W2591750377 hasConceptScore W2591750377C2778475344 @default.
• W2591750377 hasConceptScore W2591750377C2780035454 @default.
• W2591750377 hasConceptScore W2591750377C2781018059 @default.
• W2591750377 hasConceptScore W2591750377C29537977 @default.
• W2591750377 hasConceptScore W2591750377C502942594 @default.
• W2591750377 hasConceptScore W2591750377C54355233 @default.
• W2591750377 hasConceptScore W2591750377C55493867 @default.
• W2591750377 hasConceptScore W2591750377C86803240 @default.

• next